Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

95
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
95
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

131
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
131

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vagus nerve control of HMGB1 accessibility: a bioelectronic strategy for inflammation and pain.

Bioelectronic medicine·2026
Same author

Integrative Genomic, Transcriptomic, and Microbiome Profiles of Colon Cancer by Ancestry Provide Insights into Molecular Distinctions.

medRxiv : the preprint server for health sciences·2026
Same author

A comparative analysis of HMGB1 and pCTS-L immunomodulatory properties in human peripheral blood mononuclear cells.

Frontiers in immunology·2026
Same author

Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis.

Military Medical Research·2026
Same author

Central neurons encode interleukin-1β signals and mediate stress-induced inflammation.

The Journal of experimental medicine·2026
Same author

The Paediatric ACL National Audit (PANA) study: a multicentre review of UK practice and adherence to BOAST guidelines.

The Knee·2026

Related Experiment Video

Updated: Jul 12, 2025

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion
06:44

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion

Published on: February 28, 2021

4.0K

Galantamine ameliorates experimental pancreatitis.

Dane A Thompson1,2,3,4, Tea Tsaava1, Arvind Rishi5

  • 1Laboratory of Biomedical Sciences, Institute for Bioelectronic Medicine, Feinstein Institutes for Medical Research, Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.

Molecular Medicine (Cambridge, Mass.)
|November 1, 2023
PubMed
Summary

Galantamine effectively treats acute pancreatitis in mice by reducing inflammation and injury. This benefit occurs independently of the established cholinergic anti-inflammatory pathway (CAP).

Keywords:
Cholinergic anti-inflammatory pathwayCytokinesGalantamineInflammationPancreatitisVagus nerve

More Related Videos

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

588
Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

4.3K

Related Experiment Videos

Last Updated: Jul 12, 2025

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion
06:44

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion

Published on: February 28, 2021

4.0K
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

588
Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

4.3K

Area of Science:

  • Pharmacology
  • Gastroenterology
  • Immunology

Background:

  • Acute pancreatitis is a severe inflammatory condition lacking disease-modifying therapies.
  • The cholinergic anti-inflammatory pathway (CAP), mediated by alpha7 nicotinic acetylcholine receptors (α7nAChR), protects against experimental pancreatitis.
  • Galantamine, an acetylcholinesterase inhibitor, enhances the CAP but its role in pancreatitis is unclear due to muscarinic receptor involvement.

Purpose of the Study:

  • To investigate the therapeutic potential of galantamine in acute pancreatitis.
  • To elucidate the mechanism of action of galantamine in acute pancreatitis, particularly its relation to the CAP.

Main Methods:

  • Galantamine's effect on caerulein-induced acute pancreatitis was assessed in mice.
  • Pancreatic histology, serum amylase, and cytokine levels were analyzed.
  • Experiments included vagotomy, gene knockout models (choline acetyltransferase+ T cells, α7nAChR), and nAChR antagonists.

Main Results:

  • Galantamine significantly attenuated pancreatic injury, reduced inflammatory markers, and increased IL-10.
  • These protective effects were observed irrespective of vagotomy, α7nAChR knockout, or nAChR blockade.
  • The findings indicate galantamine's benefit is independent of the canonical CAP.

Conclusions:

  • Galantamine ameliorates acute pancreatitis through a novel mechanism not involving the established CAP.
  • Given galantamine's established safety profile and clinical use, further investigation in human patients is warranted.